Browsing: Lung

Anyone..? While lung cancer screening remains slow on the uptake in certain circles, there’s really no excuse for folks who…

The LungART trial showed that adjuvant radiation does not improve disease-free survival in patients with resected, N2 NSCLC. More recently,…

Like sotorasib before it, adagrasib is a novel agent showing promising efficacy for the previously deemed “undruggable” KRAS-mutated non-small cell…

Top Line: Is stereotactic radiosurgery (SRS) a safe option for patients with small cell lung cancer (SCLC) brain metastases? The…

Top Line: The clinical significance of heart dosimetry is quite difficult to tease out among patients receiving radiation for locally-advanced…

Top Line: CheckMate 816 established the benefit of adding nivolumab to neoadjuvant chemo for resectable non-small cell lung cancer (NSCLC).…

In this German retrospective study, 62 patients receiving adjuvant brain radiation and immune checkpoint inhibition following resection of non-small cell…

Patients with higher PD-L1 expression derive greater benefit from immunotherapy. So, how does that affect patients with stage III NSCLC…

Top Line: What is the risk of bronchial stenosis after 7.5 Gy x 8 for central NSCLC? The Study: This…

Maintenance durvalumab after chemoradiation (CRT) for stage III NSCLC improves median survival 18.4 months and 5-year overall survival by 9.8%.…